You have no items in your shopping cart.
You have no items in your shopping cart.

| Catalog Number | orb2663595 |
|---|---|
| Category | Small Molecules |
| Description | LS-106 is an orally active, effective epidermal growth factor receptor (EGFR) inhibitor displaying antitumor activity both in vitro and in vivo. It inhibits the kinase activities of EGFR19del/T790M/C797S and EGFRL858R/T790M/C797S, with IC50 values of 2.4 nmol/L and 3.1 nmol/L, respectively, demonstrating stronger inhibition than Osimertinib. LS-106 induces cell apoptosis (Apoptosis), suppresses the proliferation of tumor cells carrying EGFR19del/T790M/C797S, and results in significant tumor reduction in a C797S mutant xenograft model. |
| Target | Apoptosis|||EGFR |
| MW | 548.84 |
| Formula | C24H28BrClN5OP |
| Storage | -20°C |
| Research Area | Cardiovascular Research, Cell Biology, Signal Tran Read more... |
| Note | For research use only |
| Expiration Date | 12 months from date of receipt. |
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review(Recommended: An additional animal making an allowance for loss during the experiment)
(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)